Back

Efficacy and safety of percutaneous left stellate ganglion block in patients with refractory electrical storm: our five years experience.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Treatment of life-threatening arrhythmias and cardiac arrest Drug Treatment of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sara Compagnoni

University of Pavia, Pavia (Italy)

8 More presentations in this session

Presentation thumbnail
Artemisinin combined with low dose quinidine suppresses ventricular tachyarrhythmia in a model of Brugada syndrome
Doctor H. Jeong (Iksan, KR)
Abstract Slides Video
Presentation thumbnail
Single beta-blocker or combined amiodarone therapy in ICD and CRT-D patients - Insights from the German DEVICE-registry
Doctor F. Wiedmann (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study
Ms G. Monachino (Viganello, CH)
Abstract Slides Video
Presentation thumbnail
Does the type of mechanical chest compressor affect resuscitation outcome of out of hospital cardiac arrest patients? A propensity-score based comparison of three devices.
Doctor S. Savastano (Pavia, IT)
Abstract Slides
Presentation thumbnail
An innovative MedIcaL dEcision Support tool for neurological ouTcome predictiOn from post-resuscitatioN Electrocardiograms (MILESTONE)
Doctor F. Gentile (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of life-threatening arrhythmias and cardiac arrest

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?
thumbnail
Congress Session
The storm will pass…

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources